NLS Pharmaceutics AG
NASDAQ:NLSP

Watchlist Manager
NLS Pharmaceutics AG Logo
NLS Pharmaceutics AG
NASDAQ:NLSP
Watchlist
Price: 0.762 USD 2.97% Market Closed
Market Cap: 45.6m USD

Intrinsic Value

The intrinsic value of one NLSP stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.762 USD, NLS Pharmaceutics AG is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

NLSP Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
NLS Pharmaceutics AG

Intrinsic Value History
Dive into the past to invest in the future

NLSP looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NLSP usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NLSP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NLSP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for NLS Pharmaceutics AG.

Explain Valuation
Compare NLSP to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NLSP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
NLS Pharmaceutics AG

Current Assets 2.2m
Cash & Short-Term Investments 1.7m
Receivables 449.5k
Other Current Assets 110.7k
Non-Current Assets 7.5k
PP&E 7.3k
Other Non-Current Assets 200
Current Liabilities 826.8k
Accounts Payable 515.5k
Accrued Liabilities 311.3k
Efficiency

Free Cash Flow Analysis
NLS Pharmaceutics AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
NLS Pharmaceutics AG

Revenue
0 USD
Operating Expenses
-3.6m USD
Operating Income
-3.6m USD
Other Expenses
-420.7k USD
Net Income
-4.1m USD
Fundamental Scores

NLSP Profitability Score
Profitability Due Diligence

NLS Pharmaceutics AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Exceptional ROE
ROE is Increasing
hidden
Profitability
Score

NLS Pharmaceutics AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NLSP Solvency Score
Solvency Due Diligence

NLS Pharmaceutics AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

NLS Pharmaceutics AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NLSP Price Targets Summary
NLS Pharmaceutics AG

There are no price targets for NLSP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

NLS Pharmaceutics AG
does not pay dividends
Shareholder Yield

Current shareholder yield for NLSP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one NLSP stock?

The intrinsic value of one NLSP stock under the Base Case scenario is hidden USD.

Is NLSP stock undervalued or overvalued?

Compared to the current market price of 0.762 USD, NLS Pharmaceutics AG is hidden .

Back to Top